2nd Breast Cancer
Scandal: National Cancer Institute Researcher Louise Brinton Reverses
Position, Finally Admits Abortion Raises Breast Cancer Risk in Study
that Fingers Oral Contraceptives as a Probable Cause of Triple-Negative
Breast Cancer
Study is 9 months old, but still no warnings from cancer
establishment

Less than two months since the U.S. Preventative Services Task Force
issued new guidelines recommending against routine mammograms for women
in their forties, a second breast cancer scandal involving a U.S.
government panel of experts has come to light which has implications
for healthcare reform.
An April 2009 study by Jessica Dolle et al. of the Fred Hutchinson
Cancer Research Center examining the relationship between oral
contraceptives (OCs) and triple-negative breast cancer (TNBC) in women
under age 45 contained an admission from U.S. National Cancer Institute
(NCI) researcher Louise Brinton and her colleagues (including Janet
Daling) that abortion raises breast cancer risk by 40%. [1]
Additionally, Dolle's team showed that women who start OCs before age
18 multiply their risk of TNBC by 3.7 times and recent users of OCs
within the last one to five years multiply their risk by 4.2 times.
TNBC is an aggressive form of breast cancer associated with high
mortality.
"Although the study was published nine months ago," observed Karen
Malec, president of the Coalition on Abortion/Breast Cancer, "the NCI,
the American Cancer Society, Susan G. Komen for the Cure and other
cancer fundraising businesses have made no efforts to reduce breast
cancer rates by issuing nationwide warnings to women."
Brinton was the chief organizer of the 2003 NCI workshop on the
abortion-breast cancer link, which falsely assured women that the
non-existence of the link was "well established." [2]
Dolle's team reported in Table 1 a statistically significant 40% risk
increase for women who have had abortions. They listed abortion among
"known and suspected risk factors."
Brinton and Daling had previously studied this population from the
Seattle-Puget Sound area in the 1990s and reported risk increases
between 20% and 50% among women with abortions. [3,4] In the 2009
study, they and their co-authors wrote that their findings concerning
induced abortion, OC use and certain other risk factors, "were
consistent with the effects observed in previous studies on younger
women."
"Obviously, more women will die of breast cancer if the NCI fails in
its duty to warn about the risks of OCs and abortion and if government
funds are used to pay for both as a part of any healthcare bill," said
Mrs. Malec.
A brief analysis of the study (click here
http://www.abortionbreastcancer.com/download/Brind_Dolle_2009_analysis.PDF),
Dolle
et
al. 2009, was provided by Dr. Joel Brind, professor of biology
and endocrinology and deputy chair for biology at Baruch College, City
University of New York.
Last year, studies from Turkey and China also reported statistically
significant risk increases for women who had abortions. [5,6]
Click
here
for
References.
Contact: Karen Malec
Source:
Coalition on Abortion/Breast Cancer
Publish
Date:
January 6, 2010
Link
to
this
article.
Send
this
article
to
a friend.

The IFRL is the largest grassroots pro-life organization in
Illinois. A non-profit organization, that serves as the state
coordinating body for local pro-life chapters representing thousands of
Illinois citizens working to restore respect for all human life in our
society. The IFRL is composed of people of different political
persuasions, various faiths and diverse economic, social and ethnic
backgrounds. Since 1973 the Illinois Federation for Right to Life has
been working to end abortion and restore legal protection to those members of the
human family who are threatened by abortion, infanticide and euthanasia. Diverse though we are, we hold one common belief - that
every human being has an inalienable right to life that is precious and must be protected. IFRL is
dedicated to restoring the right to life to the unborn, and protection
for the disabled and the elderly. Click here to learn more about the IFRL.